Purinergic Signaling and Its Role in Mobilization of Bone Marrow Stem Cells

Methods Mol Biol. 2023:2567:263-280. doi: 10.1007/978-1-0716-2679-5_17.

Abstract

Mobilization or egress of stem cells from bone marrow (BM) into peripheral blood (PB) is an evolutionary preserved and important mechanism in an organism for self-defense and regeneration. BM-derived stem cells circulate always at steady-state conditions in PB, and their number increases during stress situations related to (a) infections, (b) tissue organ injury, (c) stress, and (d) strenuous exercise. Stem cells also show a circadian pattern of their PB circulating level with peak in early morning hours and nadir late at night. The number of circulating in PB stem cells could be pharmacologically increased after administration of some drugs such as cytokine granulocyte colony-stimulating factor (G-CSF) or small molecular antagonist of CXCR4 receptor AMD3100 (Plerixafor) that promote their egress from BM into PB and lymphatic vessels. Circulating can be isolated from PB for transplantation purposes by leukapheresis. This important homeostatic mechanism is governed by several intrinsic complementary pathways. In this chapter, we will discuss the role of purinergic signaling and extracellular nucleotides in regulating this process and review experimental strategies to study their involvement in mobilization of various types of stem cells that reside in murine BM.

Keywords: Mobilization; Mouse models; Purinergic signaling; Stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism
  • Granulocyte Colony-Stimulating Factor
  • Hematopoietic Stem Cell Mobilization*
  • Heterocyclic Compounds* / pharmacology
  • Mice
  • Nucleotides
  • Receptors, CXCR4 / metabolism

Substances

  • Receptors, CXCR4
  • Heterocyclic Compounds
  • Granulocyte Colony-Stimulating Factor
  • Nucleotides